Stockscreener 앱 받기
1.20
1.64%
-0.02
전일 마감가:
$1.22
열려 있는:
$1.24
하루 거래량:
430.33K
Relative Volume:
0.56
시가총액:
$116.60M
수익:
$11.03M
순이익/손실:
$-44.24M
주가수익비율:
-1.9355
EPS:
-0.62
순현금흐름:
$-42.61M
1주 성능:
+18.81%
1개월 성능:
+26.69%
6개월 성능:
+50.00%
1년 성능:
+23.53%
1일 변동 폭
$1.19
$1.27
1주일 범위
$0.9877
$1.305
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
HYPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.20 | 118.55M | 11.03M | -44.24M | -42.61M | -0.62 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
Energy Moves: How does Hyperfine Inc score in quality rankings2025 Earnings Impact & Short-Term Swing Trade Alerts - baoquankhu1.vn
Bedside Breakthrough: AI Brings MRI-Precision to Every Clinic - Benzinga
Hyperfine Enrolls 1st Patient in Contrast PMR Study - Medical Product Outsourcing
Hyperfine begins clinical study for contrast-enhanced portable MRI By Investing.com - Investing.com Nigeria
Hyperfine Enrolls First Patient in Contrast-Enhanced Portable MRI Study - marketscreener.com
Hyperfine, Inc. Announces Enrollment of First Patient in Study to Expand Intended Use of Swoop System with Contrast Agents - marketscreener.com
Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents - The AI Journal
Revenues Tell The Story For Hyperfine, Inc. (NASDAQ:HYPR) As Its Stock Soars 34% - simplywall.st
Treasury Yields: Is Hyperfine Inc stock showing strong momentumJuly 2025 Volume & Fast Moving Stock Watchlists - baoquankhu1.vn
Hyperfine announces workforce reduction to streamline operations - MSN
Indian Regulators Approve Hyperfine’s Swoop System - Medical Product Outsourcing
Hyperfine reports record Q4 revenue of $5.3 million, up 54% from Q3 - Investing.com Canada
Hyperfine reports preliminary Q4 revenue $5.3M, consensus $5M - TipRanks
Hyperfine Announces Strong Preliminary Q4 2025 Revenue Growth - TipRanks
Health tech firm Hyperfine prelim Q4 revenue rises 127% on Swoop system adoption - TradingView — Track All Markets
Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results - Business Wire
Published on: 2026-01-10 20:32:17 - Улправда
Hyperfine gets FDA clearance for diffusion-weighted imaging software sequence - MSN
Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates - MSN
Pulse Biosciences, Inc. Appoints Maria Sainz to its Board of Directors - FinancialContent
Can Hyperfine Inc. stock maintain growth trajectoryCEO Change & Safe Entry Trade Signal Reports - ulpravda.ru
Is Hyperfine Inc. stock attractive for long term wealth buildingWeekly Trade Review & Daily Entry Point Trade Alerts - ulpravda.ru
Is Hyperfine Inc. stock supported by strong cash flowsWeekly Stock Analysis & Expert Approved Momentum Trade Ideas - ulpravda.ru
Hyperfine (HYPR) Price Target Increased by 20.00% to 1.73 - MSN
How Hyperfine Inc. stock valuations compare to rivalsAutomated Trading Signals & Analyze Your Portfolio Risk in Seconds - Улправда
Can Hyperfine Inc. stock hit analyst price targets2026 world cup usa national team quarterfinals goalkeepers high defensive line odds analysis insights - ulpravda.ru
Star TribuneHyperfine, Inc.Class A Common Stock (Nasdaq:HYPR) Price Chart - FinancialContent
Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care - 01net
Portable MRI system shows economic benefits for hospitals By Investing.com - Investing.com South Africa
PRN_FinancialWrapper - FinancialContent
The Truth About Hyperfine Inc: Tiny Stock, Huge Hype – Is HYPR the Next Sleeper Moonshot? - AD HOC NEWS
Hyperfine, Inc. (NASDAQ:HYPR) Short Interest Down 15.6% in December - MarketBeat
Hyperfine amends at-the-market sales agreement to add BTIG as sales agent - Investing.com India
Hyperfine Inc. Reports Promising Growth in Latest Earnings Call - MSN
Hyperfine Expands ATM Equity Offering With New Sales Agent - TipRanks
Hyperfine Signs Amended ATM Sales Agreement With B. Riley Securities and BTIG - TradingView — Track All Markets
Hyperfine stock tumbles after direct offering announcement - MSN
Hyperfine announces regulatory approval of Swoop system in India - MSN
Why Hyperfine Inc. stock is favored by top institutionsMarket Activity Report & Weekly Stock Breakout Alerts - Улправда
Transcript : Hyperfine, Inc. Presents at Piper Sandler 37th Annual Healthcare Conference, Dec-04-2025 08 - marketscreener.com
Can Hyperfine Inc. stock rebound after recent weakness2025 Sector Review & Safe Capital Growth Trade Ideas - DonanımHaber
US-based Hyperfine receives regulatory approval of Swoop® System in India for brain imaging - BioSpectrum Asia
Hyperfine’s portable MRI system receives regulatory approval in India By Investing.com - Investing.com Nigeria
Hyperfine Announces Regulatory Approval of the Swoop® System in India - 01net
Hyperfine’s portable MRI system receives regulatory approval in India - Investing.com
Hyperfine announces regulatory approval of the Swoop® system in India - marketscreener.com
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Hyperfine Inc 주식 (HYPR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| TEISSEYRE THOMAS | Chief Operating Officer |
Aug 18 '25 |
Sale |
1.33 |
1,151 |
1,531 |
381,062 |
| TEISSEYRE THOMAS | Chief Operating Officer |
May 16 '25 |
Sale |
0.58 |
2,776 |
1,610 |
82,213 |
| TEISSEYRE THOMAS | Chief Operating Officer |
Feb 18 '25 |
Sale |
1.20 |
3,237 |
3,884 |
84,990 |
0.42%
1.96%
자본화:
|
볼륨(24시간):